RadSite's Complimentary Educational Session Scheduled for March 11 This webinar will clarify who may administer ...
Ferabright is the first and only iron-based contrast agent for MRI in the brainWoburn, MA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that FerabrightTM ...
Contrast-enhanced MRI demonstrated a sensitivity of 91.3% and a specificity of 68.8% in assessing high-risk breast lesions, with the potential to help patients avoid unnecessary surgery, according to ...
Precisely tuning the spacing between iron oxide nanoparticles optimizes their magnetic interactions to enhance MRI contrast, offering a simpler path to better imaging agents.
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...